3-(2-carboxyindol-3-yl)propionic acid has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haga, N; Kubota, M | 1 |
1 other study(ies) available for 3-(2-carboxyindol-3-yl)propionic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Impact of the coronavirus pandemic on families of patients with congenital insensitivity to pain with anhidrosis.
Topics: Child; COVID-19; Hereditary Sensory and Autonomic Neuropathies; Humans; Pandemics; Receptor, trkA | 2023 |